Fish Oil May be Safer Treatment than NSAID for Degenerative Disc Disease
A new study is assessing whether back and neck pain from degenerative disk disease can be helped using fish oil supplements. The supplements containing omega-3 fatty acids might be a safer treatment than nonsteroidal anti-inflammatory drugs (NSAIDs) for some individuals with nonsurgical back or neck pain.
Researchers are Joseph Maroon, MD, and Jeffrey Bost, PAC, whose study at the University of Pittsburgh Medical Center’s neurological surgery department was published in the medical journal Surgical Neurology.
One in four U.S. adults will be affected by degenerative disc disease at some time in their lives. This condition in which shock-absorbing disks in the spine wear down is one of the largest causes of pain and disability in this country.
Although NSAIDs and Cox-2 inhibitors are potent painkillers, their long-term use can lead to stomach ulcers or increased risk of heart attack or stroke. The Cox-2 inhibitors Vioxx and Bextra were removed from the market in 2004 and 2005 due to suspected heart risks.
Researchers studied 250 people seen by a neurosurgeon for nonsurgical neck or back pain. Patients were asked to take daily fish oil supplements while gradually phasing off their NSAIDs over a two week period.
Patients initially took 2.4 grams of omega-3 EFAs, after which most cut their dose to 1.2 grams daily of fish oil supplements. After taking fish oil for 75 days, patients returned surveys. Three-quarters of them reported taking 1.2 grams daily of omega-three EFAs, while the rest took 2.4 grams daily. More than half had stopped taking any NSAIDs for pain (59%).
Study finding showed the following:
• 60% of patients noted overall improvement in their pain
• 60% specifically reported less joint pain
• 80% were satisfied with their improvement
• 85% noted they would keep taking fish oil supplements
Researchers understand that patient expectations of pain relief (placebo effect) may have played a role in their reported results.
Maroon and Bost have called for additional appropriately designed studies to confirm the effectiveness of omega-3 EFAs for spine-related pain.
Researchers are Joseph Maroon, MD, and Jeffrey Bost, PAC, whose study at the University of Pittsburgh Medical Center’s neurological surgery department was published in the medical journal Surgical Neurology.
One in four U.S. adults will be affected by degenerative disc disease at some time in their lives. This condition in which shock-absorbing disks in the spine wear down is one of the largest causes of pain and disability in this country.
Although NSAIDs and Cox-2 inhibitors are potent painkillers, their long-term use can lead to stomach ulcers or increased risk of heart attack or stroke. The Cox-2 inhibitors Vioxx and Bextra were removed from the market in 2004 and 2005 due to suspected heart risks.
Researchers studied 250 people seen by a neurosurgeon for nonsurgical neck or back pain. Patients were asked to take daily fish oil supplements while gradually phasing off their NSAIDs over a two week period.
Patients initially took 2.4 grams of omega-3 EFAs, after which most cut their dose to 1.2 grams daily of fish oil supplements. After taking fish oil for 75 days, patients returned surveys. Three-quarters of them reported taking 1.2 grams daily of omega-three EFAs, while the rest took 2.4 grams daily. More than half had stopped taking any NSAIDs for pain (59%).
Study finding showed the following:
• 60% of patients noted overall improvement in their pain
• 60% specifically reported less joint pain
• 80% were satisfied with their improvement
• 85% noted they would keep taking fish oil supplements
Researchers understand that patient expectations of pain relief (placebo effect) may have played a role in their reported results.
Maroon and Bost have called for additional appropriately designed studies to confirm the effectiveness of omega-3 EFAs for spine-related pain.
Comments
Post a Comment